Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213
NCT05305989· Phase 2· Kadmon, a Sanofi Company· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error